Clostridium difficile Infection in Patients With Ileal Pouch-Anal Anastomosis

Clinical Gastroenterology and Hepatology

Volumn 6, Issue 7, 2008, Pages 782-788

  Shen, B O ^a   Jiang, Zhi Dong ^b   Fazio, Victor W ^a   Remzi, Feza H ^a   Rodriguez, Liliana ^b   Bennett, Ana E ^a   Lopez, Rocio ^a   Queener, Elaine ^a   Dupont, Herbert L ^b,c,d  

^a LERNER RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

^d ST LUKE S EPISCOPAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BACTERIAL TOXIN; CIPROFLOXACIN; RIFAXIMIN; TINIDAZOLE;

ADULT; ARTICLE; BACTERIAL INFECTION; CLINICAL ASSESSMENT; CLOSTRIDIUM DIFFICILE; CONFIDENCE INTERVAL; CROHN DISEASE; ENDOSCOPY; ENZYME LINKED IMMUNOSORBENT ASSAY; FECES; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; ILEITIS; ILEOANAL ANASTOMOSIS; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MUCOSA INFLAMMATION; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PROGNOSIS; REMISSION; RISK FACTOR; TERTIARY HEALTH CARE; TREATMENT RESPONSE; ULCERATIVE COLITIS;

ADULT; ANAL CANAL; ANASTOMOSIS, SURGICAL; BACTERIAL PROTEINS; BACTERIAL TOXINS; CLOSTRIDIUM DIFFICILE; COLITIS, ULCERATIVE; COLONIC POUCHES; DIARRHEA; ENTEROCOLITIS, PSEUDOMEMBRANOUS; ENTEROTOXINS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FECES; FEMALE; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; SEX FACTORS; UNITED STATES;

EID: 45849135980     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2008.02.021     Document Type: Article

References (42)

1. Fazio V.W., Ziv Y., Church J.M., et al. Ileal pouch-anal anastomoses complications and function in 1005 patients. Ann Surg 222 (1995) 120-127
2. Sandborn W.J. Pouchitis following ileal pouch-anal anastomosis: definition, pathogenesis, and treatment. Gastroenterology 107 (1994) 1856-1860
3. Heuschen U.A., Autschbach F., Allemeyer E.H., et al. Long-term follow-up after ileoanal pouch procedure: algorithm for diagnosis, classification, and management of pouchitis. Dis Colon Rectum 44 (2001) 487-499
4. Komanduri S., Gillevet P.M., Sikaroodi M., et al. Dysbiosis in pouchitis: evidence of unique microfloral patterns in pouch inflammation. Clin Gastroenterol Hepatol 5 (2007) 352-360
5. Duffy M., O'Mahony L., Coffey J.C., et al. Sulfate-reducing bacteria colonize pouches formed for ulcerative colitis but not for familial adenomatous polyposis. Dis Colon Rectum 45 (2002) 384-388
6. Nasmyth D.G., Godwin P.G., Dixon M.F., et al. Ileal ecology after pouch-anal anastomosis or ileostomy: a study of mucosal morphology, fecal bacteriology, fecal volatile fatty acids, and their interrelationship. Gastroenterology 96 (1989) 817-824
7. Shen B., Fazio V.W., Remzi F.H., et al. Clinical approach to diseases of ileal pouch-anal anastomosis. Am J Gastroenterol 100 (2005) 2796-2807
8. Sandborn W. Pouchitis: risk factors, frequency, natural history, classification and public health perspective. In: McLeod R.S., Martin F., Sutherland L.R., et al. (Eds). Trends in Inflammatory Bowel Disease (1997), Kluwer Academic Publishers, Lancaster, UK 51-63
9. Achkar J.P., Al-Haddad M., Lashner B., et al. Differentiating risk factors for acute and chronic pouchitis. Clin Gastroenterol Hepatol 3 (2005) 60-66
10. Shen B., Fazio V.W., Remzi F.H., et al. Risk factors for diseases of ileal pouch-anal anastomosis after restorative proctocolectomy for ulcerative colitis. Clin Gastroenterol Hepatol 4 (2006) 81-89 quiz 2-3
11. Moonka D., Furth E.E., MacDermott R.P., et al. Pouchitis associated with primary cytomegalovirus infection. Am J Gastroenterol 93 (1998) 264-266
12. Munoz-Juarez M., Pemberton J.H., Sandborn W.J., et al. Misdiagnosis of specific cytomegalovirus infection of the ileoanal pouch as refractory idiopathic chronic pouchitis: report of two cases. Dis Colon Rectum 42 (1999) 117-120
13. Mann S.D., Pitt J., Springall R.G., et al. Clostridium difficile infection: an unusual cause of refractory pouchitis-report of a case. Dis Colon Rectum 46 (2003) 267-270
14. Shen B., Goldblum J.R., Hull T.L., et al. Clostridium difficile-associated pouchitis. Dig Dis Sci 51 (2006) 2361-2364
15. Issa M., Vijayapal A., Graham M.B., et al. Impact of Clostridium difficile on inflammatory bowel disease. Clin Gastroenterol Hepatol 5 (2007) 345-351
16. Sandborn W.J., Tremaine W.J., Batts K.P., et al. Pouchitis after ileal pouch-anal anastomosis: a Pouchitis Disease Activity Index. Mayo Clin Proc 69 (1994) 409-415
17. Barbut F., Kajzer C., Planas N., et al. Comparison of three enzyme immunoassays, a cytotoxicity assay, and toxigenic culture for diagnosis of Clostridium difficile-associated diarrhea. J Clin Microbiol 31 (1993) 963-967
18. Jiang Z.D., Lowe B., Verenkar M.P., et al. Prevalence of enteric pathogens among international travelers with diarrhea acquired in Kenya (Mombasa), India (Goa), or Jamaica (Montego Bay). J Infect Dis 185 (2002) 497-502
19. Shen B., Achkar J.P., Connor J.T., et al. Modified pouchitis disease activity index: a simplified approach to the diagnosis of pouchitis. Dis Colon Rectum 46 (2003) 748-753
20. Shen B., Achkar J.P., Lashner B.A., et al. Irritable pouch syndrome: a new category of diagnosis for symptomatic patients with ileal pouch-anal anastomosis. Am J Gastroenterol 97 (2002) 972-977
21. Shen B., Fazio V.W., Remzi F.H., et al. Comprehensive evaluation of inflammatory and noninflammatory sequelae of ileal pouch-anal anastomoses. Am J Gastroenterol 100 (2005) 93-101
22. Bartlett J.G. Narrative review: the new epidemic of Clostridium difficile-associated enteric disease. Ann Intern Med 145 (2006) 758-764
23. McDonald L.C., Killgore G.E., Thompson A., et al. An epidemic, toxin gene-variant strain of Clostridium difficile. N Engl J Med 353 (2005) 2433-2441
24. Pepin J., Valiquette L., and Cossette B. Mortality attributable to nosocomial Clostridium difficile-associated disease during an epidemic caused by a hypervirulent strain in Quebec. Can Med Assoc J 173 (2005) 1037-1042
25. Rodemann J.F., Dubberke E.R., Reske K.A., et al. Incidence of Clostridium difficile infection in inflammatory bowel disease. Clin Gastroenterol Hepatol 5 (2007) 339-344
26. Meyers S., Mayer L., Bottone E., et al. Occurrence of Clostridium difficile toxin during the course of inflammatory bowel disease. Gastroenterology 80 (1981) 697-700
27. Meier C.B., Hegazi R.A., Aisenberg J., et al. Innate immune receptor genetic polymorphisms in pouchitis: is CARD15 a susceptibility factor?. Inflamm Bowel Dis 11 (2005) 965-971
28. Jiang Z.D., DuPont H.L., Garey K., et al. A common polymorphism in the interleukin 8 gene promoter is associated with Clostridium difficile diarrhea. Am J Gastroenterol 101 (2006) 1-5
29. Jiang Z.D., Garey K.W., Price M., et al. Association of interleukin-8 polymorphism and immunoglobulin G anti-toxin A in patients with Clostridium difficile-associated diarrhea. Clin Gastroenterol Hepatol 5 (2007) 964-968
30. Gosselink M.P., Schouten W.R., van Lieshout L.M., et al. Eradication of pathogenic bacteria and restoration of normal pouch flora: comparison of metronidazole and ciprofloxacin in the treatment of pouchitis. Dis Colon Rectum 47 (2004) 1519-1525
31. Chaussade S., Denizot Y., Valleur P., et al. Presence of PAF-acether in stool of patients with pouch ileoanal anastomosis and pouchitis. Gastroenterology 100 (1991) 1509-1514
32. Shen B., Achkar J.P., Lashner B.A., et al. Endoscopic and histologic evaluation together with symptom assessment are required to diagnose pouchitis. Gastroenterology 121 (2001) 261-267
33. Pepin J., Routhier S., Gagnon S., et al. Management and outcomes of a first recurrence of Clostridium difficile-associated disease in Quebec, Canada. Clin Infect Dis 42 (2006) 758-764
34. Zar F.A., Bakkanagari S.R., Moorthi K.M., et al. A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity. Clin Infect Dis 45 (2007) 302-307
35. Johnson S., Schriever C., Galang M., et al. Interruption of recurrent Clostridium difficile-associated diarrhea episodes by serial therapy with vancomycin and rifaximin. Clin Infect Dis 44 (2007) 846-848
36. Lundeen S.J., Otterson M.F., Binion D.G., et al. Clostridium difficile enteritis: an early postoperative complication in inflammatory bowel disease patients after colectomy. J Gastrointest Surg 11 (2007) 138-142
37. Taylor R.H., Borriello S.P., and Taylor A.J. Isolation of Clostridium difficile from the small bowel. Br Med J (Clin Res Ed) 283 (1981) 412
38. Testore G.P., Nardi F., Babudieri S., et al. Isolation of Clostridium difficile from human jejunum: identification of a reservoir for disease?. J Clin Pathol 39 (1986) 861-862
39. Vesoulis Z., Williams G., and Matthews B. Pseudomembranous enteritis after proctocolectomy: report of a case. Dis Colon Rectum 43 (2000) 551-554
40. Shepherd N.A., Healey C.J., Warren B.F., et al. Distribution of mucosal pathology and an assessment of colonic phenotypic change in the pelvic ileal reservoir. Gut 34 (1993) 101-105
41. Biancone L., Palmieri G., Lombardi A., et al. Tropomyosin expression in the ileal pouch: a relationship with the development of pouchitis in ulcerative colitis. Am J Gastroenterol 98 (2003) 2719-2726
42. Tysk C., Riedesel H., Lindberg E., et al. Colonic glycoproteins in monozygotic twins with inflammatory bowel disease. Gastroenterology 100 (1991) 419-423